Valiant Laboratories Limited IPO
₹133 - ₹140
105
29.76
| Open Date: | 27-Sep-2023 |
| Close Date: | 03-Oct-2023 |
| Allotment Date: | 05-Oct-2023 |
| Listing Date: | 06-Oct-2023 |
| Listing Price: | ₹184.6/- |
| Face Value: | ₹10 Per Equity Share |
| Issue Price: | ₹133-140 Per Equity Share |
| Issue Size: | Total Issue Size 10,890,000 shares (aggregating up to ₹152.46 Cr) : Fresh Issue 10,890,000 shares (aggregating up to ₹152.46 Cr) |
| Market Lot (Min Amount): | Retail - ₹14,700 : S-HNI - ₹205,800 : B-HNI - ₹1,014,300 |
As on | QIB | Nll | Rll | Total |
|---|---|---|---|---|
| Shares Offered/Reserved | 2,178,030 | 1,633,500 | 3,811,500 | 7,623,030 |
| Day 1 - 27-09-23 05:00 PM | 0.00x | 0.10x | 0.62x | 0.33x |
| Day 2 - 28-09-23 05:00 PM | 0.05x | 0.29x | 1.29x | 0.72x |
| Day 3 - 29-09-23 05:00 PM | 1.04x | 1.52x | 3.14x | 2.19x |
| Day 4 - 03-10-23 05:00 PM | 20.83x | 73.64x | 16.06x | 29.76x |
| Total No. of Application: | 6,76,145 (Approx.) | |||
| Retail Subscription on the basis of Apps: | 18.63x | |||
| Earning Per Share(EPS) | ₹8.91/- |
| P/E Ratio | 15.71 |
| RoNW | 28.86% |
| Net Asset Value (NAV) - Post Issue: | ₹N/A/- |
| Total Assets | Total Revenue | Profit After Tax | |
|---|---|---|---|
| 31 Mar,2023 | 212.76 | 338.77 | 29.00 |
| 31 Mar,2022 | 181.81 | 293.47 | 27.50 |
| 31 Mar,2021 | 106.31 | 183.78 | 30.59 |
| Pre Issue Share Holding | 100% |
| Post Issue Share Holding | 74.94% |
| 1. Shantilal Shivji Vora |
| 2. Dhanvallabh Ventures LLP (DVL) |
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
- Investment in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
- Investment in VASPL for funding its working capital requirements.
- General corporate purposes.
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.
Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.
As of April 30, 2023, Valiant Laboratories has 86 employees.
No financial information whatsoever published anywhere, within this application, should be considered as an advise to buy or sell securities or invest in IPOs, or as guide to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
Also we are not a SEBi registered analyst comapny. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this application. Above information is based on information available as on date coupled with market perceptions.
If you are agree with app tems and condition to use the app.
Thank you.